SCHEMBL13009374

SCHEMBL13009374

c1ccc2c(c1)CCc1ccccc1N2c1ccc2c(-c3ccc4ccccc4c3)c3cc(N4c5ccccc5CCc5ccccc54)ccc3c(-c3ccc(-c4cccc5ccccc45)cc3)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.37
CYP2C9 P11712 3/20 0.36
CYP2C19 P33261 3/20 0.36
CYP1A2 P05177 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
PIM1 P11309 2/20 0.34
HDAC8 Q9BY41 2/20 0.33
HDAC6 Q9UBN7 1/20 0.33
ALK Q9UM73 1/20 0.32
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
POLB P06746 1/20 0.32
KDM4E B2RXH2 1/20 0.31
CYP3A4 P08684 1/20 0.31
HTT P42858 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13428159 0.95 MET (0.39) METCYP2C9CYP2C19CYP1A2ALDH1A1
SCHEMBL13008450 0.94 CYP1A2 (0.36) METCYP2C9CYP2C19CYP1A2ALDH1A1
SCHEMBL13428125 0.94 HDAC8 (0.36) METCYP2C9CYP2C19CYP1A2ALDH1A1
SCHEMBL13427001 0.94 MET (0.37) METCYP2C9CYP2C19CYP1A2ALDH1A1
SCHEMBL13009377 0.93 PIM1 (0.35) METCYP2C9CYP2C19CYP1A2ALDH1A1
SCHEMBL13428189 0.93 CYP1A2 (0.35) METCYP2C9CYP2C19CYP1A2ALDH1A1
SCHEMBL13428147 0.92 PDE6D (0.36) CYP2C9CYP2C19CYP1A2HDAC8HDAC6
SCHEMBL13428185 0.92 HDAC8 (0.35) METCYP2C9CYP2C19CYP1A2ALDH1A1
SCHEMBL13009184 0.92 CYP1A2 (0.34) METCYP2C9CYP2C19CYP1A2ALDH1A1
SCHEMBL13009227 0.91 CYP1A2 (0.39) METCYP2C9CYP2C19CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256176-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-12-01 EP disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A MET 3253/4885CYP2C9 1228/4885CYP2C19 1844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.